Evidence map›Paper›PMID 26686687›Full record

ReviewCellular and molecular life sciences : CMLS2016

Survival regulation of leukemia stem cells.

Yiguo Hu, Shaoguang Li

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. LncRNAiScience · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Cancer stem cell characteristics and their potential as therapeutic targets.Medical oncology (Northwood, London, England) · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Live kinase B1 maintains CD34Molecular and cellular biochemistry · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Yiguo HuDepartment of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, No. 17, The Third Part Renmin South Road, Chengdu, 610041, Sichuan, China. huyiguo@scu.edu.cn.
Shaoguang LiDivision of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA. shaoguang.li@umassmed.edu.
Sichuan University · CNUniversity of Massachusetts Chan Medical School · US

Funding

Zileuton as a chemopreventive agent for chronic myeloid leukemiaR01CA176179 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LI, SHAOGUANG · 2014 to 2018
$1.7M
NCI NIH HHS R01 CA176179
6 · The paper itself

Abstract

Leukemia stem cells (LSCs) are a subpopulation cells at the apex of hierarchies in leukemia cells and responsible for disease continuous propagation. In this article, we discuss some cellular and molecular components, which are critical for LSC survival. These components include intrinsic signaling pathways and extrinsic microenvironments. The intrinsic signaling pathways to be discussed include Wnt/β-catenin signaling, Hox genes, Hh pathway, Alox5, and some miRNAs, which have been shown to play important roles in regulating LSC survival and proliferation. The extrinsic components to be discussed include selectins, CXCL12/CXCR4, and CD44, which involve in LSC homing, survival, and proliferation by affecting bone marrow microenvironment. Potential strategies for eradicating LSCs will also discuss.

Indexed as

Signal TransductionAnimalsArachidonate 5-LipoxygenaseCell SurvivalGene Expression Regulation, LeukemicHedgehog ProteinsHomeodomain ProteinsHumansLeukemiaMicroRNAsNeoplastic Stem CellsTumor MicroenvironmentALOX5 protein, humanArachidonate 5-LipoxygenaseHedgehog ProteinsHomeodomain ProteinsMicroRNAsAlox5AMLCMLHhHoxLSCMicroenvironmentmiRNAWnt

Identifiers

PMID26686687
PMCPMC11108378
OpenAlexW2287899422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.